Africans facing coronavirus must not suffer the injustices they saw with Aids | Lydia Namubiru

Patients were used as guinea pigs but denied access to resulting therapies. This time, Big Pharma must be held to account Coronavirus – latest updates See all our coronavirus coverage The year I turned 11, my uncle Josiah Ssesanga was admitted to a hospital in Uganda with meningitis. It was 1994, and he was HIV positive. Between him and death stood a tattered post-civil war health system. Treatments for HIV and Aids existed in other parts of the world, but in Uganda they were mostly limited to those used in clinical trials. For my uncle’s particular infection – cryptococcal meningitis – there was a drug called Fluconazole. But he didn’t know it existed; regardless, he wouldn’t have been able to afford it. and even among patients who took it, only 12% survived beyond six months. Continue reading...